|
SUNDAY, MAY 11
RECOMMENDED SHORT COURSE*
(SC1) Cardiac Safety: Improving Pre-Clinical Predictions to Better Clinical Outcomes
Cardiotoxicity is one of the major forms of toxicity seen in drugs and it accounts for most recalls and delays experienced in drug approvals. One of the biggest challenges is how to predict cardiac risk associated with drug candidates very early and accurately in the drug development process. The course will provide an overview of the recent technical and scientifi c advances in preclinical testing for determining cardiac safety. The instructors will also talk about ways to then effectively combine the intelligence gathered from preclinical screens with clinical data and post-marketing studies to better assess the safety of new drug candidates.
View Short Course
Schedule
*Separate Registration Required
|
